您当前的位置：
首页 >
文章列表页 >
Rapid health technology assessment of deucravacitinib in the treatment of moderate-to-severe plaque psoriasis
更新时间：2026-02-10

    • Rapid health technology assessment of deucravacitinib in the treatment of moderate-to-severe plaque psoriasis

    • “The efficacy, safety, and cost-effectiveness of deuteroxenib in the treatment of moderate to severe plaque psoriasis are good, and more research is needed to improve the evaluation in the future.”
    • ZHONGGUO YAOFANG   Vol. 37, Issue 1, Pages: 111-116(2026)

    • DOI：10.6039/j.issn.1001-0408.2026.01.20    

      CLC： R986;R956;R969.3

    • Received：27 September 2025，

      Revised：2025-12-16，

      Accepted：17 December 2025，

      Published：15 January 2026

    移动端阅览

  • GAO Xing,KONG Shujing,LIU Tianya,et al.Rapid health technology assessment of deucravacitinib in the treatment of moderate-to-severe plaque psoriasis[J].ZHONGGUO YAOFANG,2026,37(01):111-116. DOI： 10.6039/j.issn.1001-0408.2026.01.20.

  •  
  •  

0

Views

15

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Dupilumab for the treatment of severe asthma： a rapid health technology assessment
Tenecteplase in the treatment of acute ischemic stroke： a rapid health technology assessment
Clinical evaluation of anlotinib in third-line treatment for advanced non-small cell lung cancer based on real-world data
Rapid health technology assessment of serplulimab in the first-line treatment of small-cell lung cancer
Evaluation of the efficacy， safety and cost-effectiveness of different formulations of short-acting rhGH in the treatment of patients with short stature

Related Author

DONG Shichao
SUN Wei
WANG Huayu
WANG Ying
LI Huiting
MEN Peng
ZHANG Zhetao
ZHANG Jin

Related Institution

Dept. of Pharmacy，the Second Hospital of Tianjin Medical University
Dept. of Respiratory， the Second Hospital of Tianjin Medical University
Dept. of Pharmacy， the First Affiliated Hospital of USTC （Anhui Provincial Hospital）
Anhui Provincial Key Laboratory of Precision Pharmaceutical Preparations and Clinical Pharmacy
Dept. of Pharmacy， Peking University Third Hospital
0